Article, Early Access, 2024

Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, ISSN 0269-2813, 10.1111/apt.18147

Contributors

Johannessen, Asgeir (Corresponding author) [1] [2] Reikvam, Dag Henrik [1] Aleman, Soo [3] [4] Berhe, Nega [1] [2] [5] Weis, Nina [6] Desalegn, Hailemichael [2] [7] Stenstad, Tore [2] Heggelund, Lars [8] Samuelsen, Ellen [1] Karlsen, Lars Normann [9] Lindahl, Karin [3] [4] Pettersen, Frank Olav [1] Iversen, Jonas [1] Kleppa, Elisabeth [1] Bollerup, Signe [6] Winckelmann, Anni Assing [6] Brugger-Synnes, Pascal [10] Simonsen, Hans Erling [11] Svendsen, Jan [12] Kran, Anne-Marte Bakken [1] [13] Holmberg, Marte [2] Olsen, Inge Christoffer [1] Rueegg, Corina Silvia [1] Dalgard, Olav [1]

Affiliations

  1. [1] Akershus Univ Hosp, Dept Infect Dis, Lorenskog, Norway
  2. [NORA names: Norway; Europe, Non-EU; Nordic; OECD];
  3. [2] Vestfold Hosp Trust, Dept Infect Dis, N-3103 Tonsberg, Norway
  4. [NORA names: Norway; Europe, Non-EU; Nordic; OECD];
  5. [3] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
  6. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  7. [4] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
  8. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  9. [5] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia
  10. [NORA names: Ethiopia; Africa];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Data Provider: Clarivate